— Know what they know.
Not Investment Advice

OPTN NASDAQ

OptiNose, Inc.
1W: +1.9% 1M: +4.7% 3M: +60.0% 1Y: -49.2% 3Y: -65.4% 5Y: -83.6%
$9.60
Last traded 2025-05-21 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $97.2M mcap · 6M float · 1.87% daily turnover · Short 18% of daily vol

Cash Flow Trends

Operating Cash Flow
-$45M -118.6% ▼
Capital Expenditures
$72K +78.0% ▲
5Y CAGR: -33.6%
Free Cash Flow
-$45M -114.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 -100.0% ▼
Net Change in Cash
$11M +152.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$100M-$82M-$75M-$35M-$22M
Depreciation & Amort.$1M$646K$532K$402K$283K
Stock-Based Comp.$10M$10M$9M$5M$6M
Change in Working Capital-$96K-$7M-$6M$12M-$20M
Other Non-Cash Items$1M$2M$4M-$3M-$10M
Operating Cash Flow-$86M-$77M-$68M-$21M-$45M
— Investing Activities —
Capital Expenditures-$546K-$167K-$63K-$328K-$72K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$105K$0$0$0
Investing Cash Flow-$546K-$62K-$63K-$328K-$72K
— Financing Activities —
Net Debt Issuance$50M$0$0$0$0
Stock Repurchased$0$0$0$299K$0
Dividends Paid$0$0$0$0$0
Other Financing$210K$180K$350K$300K$76K
Financing Cash Flow$84M$43M$51M$300K$56M
Net Change in Cash-$3M-$34M-$16M-$21M$11M
Cash End of Period$144M$111M$94M$74M$84M
Free Cash Flow-$87M-$77M-$68M-$21M-$45M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms